TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04684602: Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Sponsor: Thomas Advanced Medical LLC · Phase: PHASE1/PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 5000 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$9,384,000

Rescue Site Savings

+$6,187,575

Unlock Full NCT04684602 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04684602 Rescue Dossier →